DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,101,133 shares of the medical instruments supplier’s stock after purchasing an additional 35,360 shares during the period. Charles Schwab Investment Management Inc. owned 1.06% of DENTSPLY SIRONA worth $39,880,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares during the period. MML Investors Services LLC boosted its holdings in DENTSPLY SIRONA by 2.1% in the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after acquiring an additional 620 shares during the last quarter. Blue Trust Inc. grew its position in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock valued at $137,000 after acquiring an additional 707 shares during the period. KBC Group NV increased its stake in DENTSPLY SIRONA by 19.9% during the third quarter. KBC Group NV now owns 6,274 shares of the medical instruments supplier’s stock worth $170,000 after acquiring an additional 1,040 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its stake in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Up 3.7 %

NASDAQ:XRAY opened at $15.56 on Friday. DENTSPLY SIRONA Inc. has a one year low of $14.77 and a one year high of $33.72. The business’s 50-day simple moving average is $18.22 and its 200 day simple moving average is $20.83. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market cap of $3.10 billion, a price-to-earnings ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Analyst Ratings Changes

A number of analysts have recently issued reports on XRAY shares. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday. Finally, Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $23.33.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.